Development and prospective evaluation of a machine learning model to predict vomiting among pediatric cancer and

Adam Paul Yan1,2, Lin Lawrence Guo2, Priya Patel1,3

  • 1Division of Haematology/Oncology, The Hospital for Sick Children, 555 University Avenue, Toronto, ON, M5G1X8, Canada.

BMC Cancer
|November 1, 2025
PubMed

Insights

A machine learning model using electronic health records can predict vomiting risk in pediatric oncology and hematopoietic cell transplant patients. This model showed consistent performance in a prospective trial, paving the way for clinical integration.

Area of Science:

  • Machine learning applications in healthcare
  • Predictive modeling in oncology
  • Electronic health record data utilization

Background:

  • Vomiting is a common side effect for pediatric patients undergoing oncology and hematopoietic cell transplant (HCT) treatments.
  • Accurate prediction of vomiting risk is crucial for timely intervention and improved patient care.

Purpose of the Study:

  • To develop a machine learning (ML) model using electronic health record (EHR) data to predict vomiting risk within 96 hours for pediatric oncology and HCT patients.
  • To prospectively evaluate the developed ML model's performance in a silent trial.

Main Methods:

  • Utilized retrospective EHR data from SEDAR (2018-2024) and conducted a prospective silent trial (2024).
  • Trained and compared L2-regularized logistic regression, LightGBM, and XGBoost models.
  • The outcome was defined as any vomiting within 96 hours post-prediction time.

Main Results:

  • The best-performing model, LightGBM trained on all inpatients, achieved an AUROC of 0.730 retrospectively and 0.716 prospectively.
  • The model utilized 2,859 features and was evaluated on 7,408 retrospective and 340 prospective admissions.
  • The ML model demonstrated satisfactory predictive performance in both retrospective and prospective phases.

Conclusions:

  • EHR data can effectively train ML models to predict vomiting in pediatric oncology and HCT inpatients.
  • The developed ML model maintained its predictive accuracy in a prospective silent trial.
  • Future work will focus on clinical workflow integration and assessing the model's impact on vomiting control.
Abstract